MEI Pharma, Inc. reported earnings results for the second quarter and six months ended December 31, 2021. For the second quarter, the company reported sales was USD 18.22 million compared to USD 9.17 million a year ago. Net loss was USD 5.77 million compared to USD 11.45 million a year ago. Basic loss per share from continuing operations was USD 0.05 compared to USD 0.1 a year ago. Diluted loss per share from continuing operations was USD 0.09 compared to USD 0.16 a year ago.
For the six months, sales was USD 31.61 million compared to USD 13 million a year ago. Net loss was USD 17.65 million compared to USD 13.55 million a year ago. Basic loss per share from continuing operations was USD 0.15 compared to USD 0.12 a year ago. Diluted loss per share from continuing operations was USD 0.22 compared to USD 0.3 a year ago.